You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 19, November 19, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Informatics/ Internet in Medicine
 •Informatics, Other
 •Statistics and Research Methods
 •Genetics
 •Genetics, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Organizational Improvements to Enhance Modern Clinical Epidemiology

Robert M. Califf, MD; Geoffrey S. Ginsburg, MD, PhD

JAMA. 2008;300(19):2300-2302.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Unprecedented investments in biological sciences and information technology are catalyzing revolutionary changes in clinical epidemiology and redefining human health and disease, as well as the approach to disease classification and treatment.1 However, the potential of these innovations will only be realized within a biomedical enterprise that develops appropriate strategies for their use. Seven facets—traditional clinical epidemiology; biobanks; genomics and molecular profiling; imaging; bioinformatics; biostatistics; and decision making—are critical to this new approach but must be placed within a systems framework that integrates each discipline's contributions. Connecting these once-isolated spheres of endeavor would benefit clinicians and the public, if necessary preconditions are met.

Clinical disease states reflect complex interactions of genetic, environmental, and behavioral contributions, but tools for identifying and quantifying these factors simultaneously are only now being developed. The speed with which pragmatic effects on practice can be achieved now depends . . . [Full Text of this Article]

Clinical Epidemiology

Author Affiliations: Duke Translational Medicine Institute (Dr Califf) and the Duke Institute for Genome Sciences & Policy (Dr Ginsburg), Duke University Medical Center, Durham, North Carolina.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.